Heartflow, Inc. · NASDAQ:HTFL

Rogers Campbell sold 111,412 Heartflow, Inc. shares (Form 4)

Traded Feb 20 to Nov 17, 2026 · Filed Nov 19, 2026

From Feb 20 to Nov 17, 2026, Rogers Campbell (Chief Medical Officer) sold 111,412 Heartflow, Inc. shares at an average US$37.86 for US$4.22M under a trading plan, leaving 6,503 shares. Filed Nov 19, 2026 (Form 4).

Sold
111,412 shares
Price
US$37.86 average (US$24.40 to US$55.01)
Value
US$4.22M
Holding after
6,503 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Feb 20, 2026Common StockSale16,918US$24.4033,836Indirect
Mar 19, 2026Common StockSale16,918US$25.0016,918Indirect
Apr 1, 2026Common StockSale16,918US$24.670Indirect
Sep 18, 2026Common StockSale5,653US$50.1516,962Indirect
Sep 18, 2026Common StockSale6,503US$50.1519,509Indirect
Oct 22, 2026Common StockSale5,654US$55.0111,308Indirect
Oct 22, 2026Common StockSale6,503US$55.0113,006Indirect
Nov 17, 2026Common StockOption exercise12,328US$8.3383,511Direct
Nov 17, 2026Common StockOption exercise5,101US$2.2288,612Direct
Nov 17, 2026Common StockSale24,188US$46.3964,424Direct
Nov 17, 2026Common StockSale5,654US$46.395,654Indirect
Nov 17, 2026Common StockSale6,503US$46.396,503Indirect

Source

Download original · View original at SEC

Related